These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19477198)

  • 1. Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse.
    Tóth A; Szilágyi O; Krasznai Z; Panyi G; Hajdú P
    Immunol Lett; 2009 Jun; 125(1):15-21. PubMed ID: 19477198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol modifies the gating of Kv1.3 in human T lymphocytes.
    Hajdú P; Varga Z; Pieri C; Panyi G; Gáspár R
    Pflugers Arch; 2003 Mar; 445(6):674-82. PubMed ID: 12632187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glycosylation state of Kv1.2 potassium channels affects trafficking, gating, and simulated action potentials.
    Watanabe I; Zhu J; Sutachan JJ; Gottschalk A; Recio-Pinto E; Thornhill WB
    Brain Res; 2007 May; 1144():1-18. PubMed ID: 17324383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment on "Functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse".
    Bittner S; Wiendl H; Meuth SG
    Immunol Lett; 2009 Aug; 125(2):156-7. PubMed ID: 19595706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Kv1.1 channel glycosylation on C-type inactivation and simulated action potentials.
    Sutachan JJ; Watanabe I; Zhu J; Gottschalk A; Recio-Pinto E; Thornhill WB
    Brain Res; 2005 Oct; 1058(1-2):30-43. PubMed ID: 16153617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid potently inhibits both postsynaptic-type Kv4.2 and presynaptic-type Kv1.4 IA potassium channels.
    Angelova PR; Müller WS
    Eur J Neurosci; 2009 May; 29(10):1943-50. PubMed ID: 19453640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open form of syntaxin-1A is a more potent inhibitor than wild-type syntaxin-1A of Kv2.1 channels.
    Leung YM; Kang Y; Xia F; Sheu L; Gao X; Xie H; Tsushima RG; Gaisano HY
    Biochem J; 2005 Apr; 387(Pt 1):195-202. PubMed ID: 15518587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface expression and channel gating.
    Solé L; Roura-Ferrer M; Pérez-Verdaguer M; Oliveras A; Calvo M; Fernández-Fernández JM; Felipe A
    J Cell Sci; 2009 Oct; 122(Pt 20):3738-48. PubMed ID: 19773357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMJ-53A accelerates slow inactivation gating of voltage-gated K+ channels in mouse neuroblastoma N2A cells.
    Chao CC; Shieh J; Kuo SC; Wu BT; Hour MJ; Leung YM
    Neuropharmacology; 2008 Jun; 54(7):1128-35. PubMed ID: 18406431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modulatory effect of zinc ions on voltage-gated potassium currents in cultured rat hippocampal neurons is not related to Kv1.3 channels.
    Teisseyre A; Mercik K; Mozrzymas JW
    J Physiol Pharmacol; 2007 Dec; 58(4):699-715. PubMed ID: 18195482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective agent riluzole dramatically slows inactivation of Kv1.4 potassium channels by a voltage-dependent oxidative mechanism.
    Xu L; Enyeart JA; Enyeart JJ
    J Pharmacol Exp Ther; 2001 Oct; 299(1):227-37. PubMed ID: 11561084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate levels and activity of the T cell voltage-gated potassium Kv1.3 channel in patients with systemic lupus erythematosus.
    Poulopoulou C; Papadopoulou-Daifoti Z; Hatzimanolis A; Fragiadaki K; Polissidis A; Anderzanova E; Davaki P; Katsiari CG; Sfikakis PP
    Arthritis Rheum; 2008 May; 58(5):1445-50. PubMed ID: 18438846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Answer to the "comment on functional consequences of Kv1.3 ion channel rearrangement into the immunological synapse" by Stefan Bittner et al. [Immunol. Lett. 125 (Aug 15 (2)) (2009) 156-157].
    Hajdú P; Szilágyi O; Tóth A; Krasznai Z; Pocsai K; Panyi G
    Immunol Lett; 2010 Mar; 129(1):47-9. PubMed ID: 20079762
    [No Abstract]   [Full Text] [Related]  

  • 14. Electrophysiologic characterization of a novel hERG channel activator.
    Su Z; Limberis J; Souers A; Kym P; Mikhail A; Houseman K; Diaz G; Liu X; Martin RL; Cox BF; Gintant GA
    Biochem Pharmacol; 2009 Apr; 77(8):1383-90. PubMed ID: 19426677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kv1 potassium channel C-terminus constant HRETE region: arginine substitution affects surface protein level and conductance level of subfamily members differentially.
    Zhu J; Gomez B; Watanabe I; Thornhill WB
    Mol Membr Biol; 2007; 24(3):194-205. PubMed ID: 17520476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
    Zhang HX; Zhang W; Jin HW; Wang XL
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):136-40. PubMed ID: 15530663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of membrane lipid metabolites on lymphocyte potassium channel activity.
    Teisseyre A; Michalak K; Kuliszkiewicz-Janus M
    Cell Mol Biol Lett; 2002; 7(4):1095-109. PubMed ID: 12511977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation of Kv1 channel-mediated currents by co-expression of Kvbeta3 subunit in a mammalian cell-line.
    Bähring R; Vardanyan V; Pongs O
    Mol Membr Biol; 2004; 21(1):19-25. PubMed ID: 14668135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental switch of the expression of ion channels in human dendritic cells.
    Zsiros E; Kis-Toth K; Hajdu P; Gaspar R; Bielanska J; Felipe A; Rajnavolgyi E; Panyi G
    J Immunol; 2009 Oct; 183(7):4483-92. PubMed ID: 19748986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N type rapid inactivation in human Kv1.4 channels: functional role of a putative C-terminal helix.
    Sankaranarayanan K; Varshney A; Mathew MK
    Mol Membr Biol; 2005; 22(5):389-400. PubMed ID: 16308273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.